2Whitworth JA,World Health Organization,International So-ciety of Hypertension Writing Group.2003 World Health Or-ganization (WHO)Antemational Society of Hypertension (ISH)statement on management of hypertension [J]J Hypertens,2003,21(11):1983-1992. 被引量：1
3Patel BM, Mehta AA.Aldosterone and angiotensin : Role indiabetes and cardiovascular disease [J].Eur J Pharmacol,2012,697(1-3):1-12. 被引量：1
4Mansia G,De Backer G,Dominiczak A,et al.2007 Guide-lines for management of arterial hypertension : the Task Forcefor the Management of Arterial Hypertension of the EuropeanSociety of Hypertension (ESH) and of the European Society ofCardiology(ESC)[J]. J Hypertens, 2007,25(6) : 1105-1187. 被引量：1
5Vegter S, de Jong-van den Berg LT. Misdiagnosis and mis-treatment of a common side—effect—angiotensin—convertingenzyme inhibitor induced cough [J].Br J Clin Pharmacol,2010,69(2) :200-203. 被引量：1
6Tardif JC,Curaew GP,Leclerc JM,et al.Reaching the thera-peutic goal in hypertension : results from the Canadian val-sartan observational study[J].Can J Clin Pharmacol,2008,15(2):el77-187. 被引量：1
